Clinical Trial Update: IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IV iron replacement for iron deficiency in idiopathic pulmonary arterial hypertension completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency
• Pulmonary Arterial Hypertension

Snippet

Sponsor: Imperial College London | Conditions: Pulmonary Arterial Hypertension, Iron Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2022-03-07